What is Lm Technology?
Robert Petit, MD, Chief Scientific Officer of Advaxis, Inc. gives an overview of Advaxis' Lm Technology, which alters Listeria monocytogenes (Lm) bacteria to stimulate cancer-fighting T-cells directe...
Author: ASCO2017
Added: 06/14/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts